Dr. H. BONTINCK

Active

Private limited companyfounded 2005active for 21 yearsKokkelbeekplein 2, 9100 Sint-Niklaas, BelgiumKBO/BCE: BE 0871.331.402

From the official registers: KBO 21 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. H. BONTINCK has been active since 2005 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €218,988 and a net result of €19,576. Equity is growing by about 17% per year across the filed financial years. Its solvency ranks better than 90% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow Report Compare

Dr. H. BONTINCKActiveChecked score 95/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 20-01-2005 Normal situation
Legal form: Private limited company
Registered office: Kokkelbeekplein 2, 9100 Sint-Niklaas
Activity: Specialist medical practice NACE 86220
Establishment unit: 2.302.234.127 9100 Sint-Niklaas, since 20-01-2005
Financial year end: 31 December
Peppol: Not found in the Peppol Directory

Company details

Who decides

Board

Bontinck HugoDirector

Holdings: Shares in 1 company ASSOCIATIE HEELKUNDE AZR-BBV

Board & ownership

How it is doing

95 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: < 0.1%

Annual accounts 2025

Gross margin: €30,989; ▼ 69.4%
Turnover: ≈ €95,000; estimated
Profit: €19,576; ▼ 67.6%
Equity: €218,988; ▲ 3.6%
Total assets: €232,881; ▲ 3.1%

2025 accounts 32 days early

Filed on 29-06-2026at the National Bank

Financials

Why 95raises risk1 change of registered office in 24 monthslowers riskLiquidity: current ratio 15.51, cash €153,016Sector: Human health activities (NACE 86)Equity €218,988 (94.0% of total assets)Show the evidence

Checked score

Score 2025

95 / 100

Excellent

Probability in this band: under 0.55%

Financially better than 62% of its sector peers (NACE 86, micro)

Every signal that counts is listed under Signals.

Financial strength · tick = 2024

Strong

Solvency 100=

equity 94.0% of total assets

Liquidity 100=

short-term debt 6.0% · cash 65.7%

Profitability 79-21

return on assets 8.4%

Bankruptcy probability, 12 months

< 0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)

Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● unchanged vs 11-2024lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026

Credit of up to €20,000 on 30-day terms is acceptable

Liquidity ample (current ratio 15.51, compared with 14.75 in 2024, above the usual 1.5; short-term debt: 6% and cash: 65.7% of total assets), and 6% of the assets are financed with debt and provisions.

How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 25% on profitability and 44% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.

lowers riskraises riskneutral

Liquidity: current ratio 15.51, cash €153,016

NBB · annual accounts

1 change of registered office in 24 months

Belgian Official Gazette

Sector: Human health activities (NACE 86)

KBO

Equity €218,988 (94.0% of total assets)

NBB · annual accounts

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

32 days early

2024

14 days early

2023

15 days early

2022

101 days late

2021

114 days late

2020

61 days late

2019

89 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 43 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 July (4 of the last 5 filed years within 115 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

Searched since 2021.

KBO publications · our coverage

Key points

Positive: Among the best 11% on solvencysector median 63.0% · 20,678 companies 94.0% View
Positive: 8 profitable years in a rowprofit 2025: €19,576 8 years View

Documents

Key facts about Dr. H. BONTINCK

What is the company number of Dr. H. BONTINCK?: 0871.331.402. In Belgium the VAT number is the company number with BE in front: BE 0871.331.402.
Where is Dr. H. BONTINCK based?: The registered office is at Kokkelbeekplein 2, 9100 Sint-Niklaas.Company details
What does Dr. H. BONTINCK do?: According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. H. BONTINCK?: Private limited company (BV).
When was Dr. H. BONTINCK founded?: On 20-01-2005.
Is Dr. H. BONTINCK still active?: Yes, Dr. H. BONTINCK is an active enterprise in the KBO register.
What is the turnover of Dr. H. BONTINCK?: ≈ €95,000 in financial year 2025. Estimated from the gross margin of €30,989: probably between €69,000 and €130,000, based on 47 comparable companies, NACE 86.Financials
Is Dr. H. BONTINCK profitable?: In financial year 2025, Dr. H. BONTINCK made a profit of €19,576.
Where can I find the annual accounts of Dr. H. BONTINCK?: Dr. H. BONTINCK filed 21 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. H. BONTINCK due?: By 31-07-2027, for financial year 2026.Timeline